Using SGLT2 Inhibitors to Achieve Cardiovascular Benefits
Darren K. McGuire, MD, MHSc, remarks on his personal experience utilizing SGLT2 inhibitors to help patients achieve cardiovascular benefits and reacts to the reluctance by cardiologists to prescribe the class of drugs for appropriate patients.